Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Lederer

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Annals of the American Thoracic Society|February 5, 2019
Reply: Ethics of Health Research Supported by For-Profit Cannabis Companies: What Have We Learned from Big Tobacco?David J Lederer
American Journal of Respiratory and Critical Care Medicine|April 3, 2012
Secondary prevention of idiopathic pulmonary fibrosis: catching the horse still in the barnDavid J Lederer
Annals of the American Thoracic Society|December 2, 2017
AnnalsATS 2022: Rigor, Value, ImpactDavid J Lederer
The European Respiratory Journal|December 3, 2013
Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forwardDavid J Lederer
Annals of the American Thoracic Society|October 25, 2014
Embracing complex diseases. The case for an idiopathic pulmonary fibrosis biorepositoryDavid J Lederer
American Journal of Respiratory and Critical Care Medicine|September 2, 2016
Reply: Disparities in Access to Lung Transplantation-More Than Meets the EyeDavid J Lederer, Jessica Sell
Thorax|March 11, 2017
Diagnosing idiopathic pulmonary fibrosis without a lung biopsy: honeycombing not requiredRobert Homer, David J Lederer
Chest|October 7, 2018
Focus on Idiopathic Pulmonary Fibrosis: Advancing Approaches to Diagnosis, Prognosis, and TreatmentFernando J Martinez, David J Lederer
Annals of the American Thoracic Society|October 9, 2015
Editors' Introduction to AnnalsATS Clinical Research Design ArticlesDavid J Lederer, John Hansen-Flaschen
The New England Journal of Medicine|May 10, 2018
Idiopathic Pulmonary FibrosisDavid J Lederer, Fernando J Martinez
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Annals of the American Thoracic Society|February 5, 2019
Reply: Ethics of Health Research Supported by For-Profit Cannabis Companies: What Have We Learned from Big Tobacco?David J Lederer
American Journal of Respiratory and Critical Care Medicine|April 3, 2012
Secondary prevention of idiopathic pulmonary fibrosis: catching the horse still in the barnDavid J Lederer
Annals of the American Thoracic Society|December 2, 2017
AnnalsATS 2022: Rigor, Value, ImpactDavid J Lederer
The European Respiratory Journal|December 3, 2013
Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forwardDavid J Lederer
Annals of the American Thoracic Society|October 25, 2014
Embracing complex diseases. The case for an idiopathic pulmonary fibrosis biorepositoryDavid J Lederer
American Journal of Respiratory and Critical Care Medicine|September 2, 2016
Reply: Disparities in Access to Lung Transplantation-More Than Meets the EyeDavid J Lederer, Jessica Sell
Thorax|March 11, 2017
Diagnosing idiopathic pulmonary fibrosis without a lung biopsy: honeycombing not requiredRobert Homer, David J Lederer
Chest|October 7, 2018
Focus on Idiopathic Pulmonary Fibrosis: Advancing Approaches to Diagnosis, Prognosis, and TreatmentFernando J Martinez, David J Lederer
Annals of the American Thoracic Society|October 9, 2015
Editors' Introduction to AnnalsATS Clinical Research Design ArticlesDavid J Lederer, John Hansen-Flaschen
The New England Journal of Medicine|May 10, 2018
Idiopathic Pulmonary FibrosisDavid J Lederer, Fernando J Martinez
Pageof 22